Schistosoma: Difference between revisions
From IDWiki
Schistosoma
No edit summary |
(ββ) |
||
| Line 3: | Line 3: | ||
== Species == |
== Species == |
||
* '' |
* ''[[Schistosoma mansoni]]'': liver and gut |
||
* '' |
* ''[[Schistosoma haematobium]]'': GU/pelvis |
||
* '' |
* ''[[Schistosoma japonicum]]'': liver and gut |
||
* '' |
* ''[[Schistosoma mekongi]]'': Mekong basin |
||
== Risk Factors == |
== Risk Factors == |
||
Revision as of 18:42, 10 December 2019
- Infection with a species of the genus Schistosoma
Species
- Schistosoma mansoni: liver and gut
- Schistosoma haematobium: GU/pelvis
- Schistosoma japonicum: liver and gut
- Schistosoma mekongi: Mekong basin
Risk Factors
- Fresh water exposure in endemic countries
Clinical Presentation
Investigations
- Labs
- CBC, showing eosinophilia
- Schisto serology (only positive 6 weeks after infection)
- Egg detection in stool, urine, semen, or tissue biopsy
- Imaging
- Eggs can cause granulomatous disease in various organs
- Bladder polyps and obstruction may be seen on ultrasound
Management
- Acute
- Praziquantel 40mg/kg/d
- Can cause nausea, dizziness, and fever
- Praziquantel 40mg/kg/d
- Chronic
- Prevention
Prognosis
- Increased risk of squamous cell carcinoma, which increase with young age at infection, duration of infection, high burden of infection, and bladder wall fibrosis
References
- ^ Archana Asundi, Alina Beliavsky, Xing Jian Liu, Arash Akaberi, Guido Schwarzer, Zeno Bisoffi, Ana Requena-MΓ©ndez, Ian Shrier, Christina Greenaway. Prevalence of strongyloidiasis and schistosomiasis among migrants: a systematic review and meta-analysis. The Lancet Global Health. 2019;7(2):e236-e248. doi:10.1016/s2214-109x(18)30490-x.
